Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

A Modular Cloud Platform For Fertility Preservation

11. juni 2026 opdateret af: Nezihe KIZILKAYA BEJI, Biruni University

A Modular CLoud Based Platform To Enhance Fertility Preservation Awareness: Design, Pilot Testing And Randomized Controlled Trial

The research was designed as a randomized controlled study to determine the effectiveness of a modular cloud-based training platform in increasing awareness of fertility preservation.

The study aims to develop a free, modular, cloud-based, sustainable digital platform to increase fertility awareness. The platform will provide basic information on fertility preservation methods in plain language to support informed decisions. Content will be based on European Society of Human Reproduction and Embryology (ESHRE) , International Federation of Gynaecology and Obstetrics (FIGO) and Asian Society of Gynecologic Oncology (ASCO) guidelines. The study targets not only cancer patients but also women requesting fertility preservation for medical or social reasons.

In the first stage, the platform will be designed with the ADDIE instructional design model (Analysis, Design, Development, Implementation, Evaluation) and content created per international guidelines. In the second stage, the prototype will be pilot-tested and revised. In the third stage, effectiveness will be tested through a randomized controlled trial. Educational modules will be provided to the intervention group, while the control group will receive brochures. The study will include women aged 18-45 with early-stage gynecological cancer (cervix, ovary, tube, endometrium) at Prof. Dr. Cemil Tascioglu City Hospital, untreated. Participants must have Turkish literacy and internet access. Sample size, calculated with G*Power, is 140 total (70 per group).

Studieoversigt

Detaljeret beskrivelse

This is a randomized controlled experimental study. The research was carried out in the Prof. Dr. Cemil Tascioglu City Hospital.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

140

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Nezihe KIZILKAYA BEJI, Professor
  • Telefonnummer: 90+ 0532 502 34 94
  • E-mail: nbeji@biruni.edu.tr

Undersøgelse Kontakt Backup

Studiesteder

    • Zeytinburnu
      • Istanbul, Zeytinburnu, Tyrkiet (Türkiye), 34020
        • Biruni University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Women of reproductive age between the ages of 18 and 45,
  • Diagnosed with early stage cervical cancer, ovarian cancer, tubal cancer and endometrial cancer and whose treatment has not started,
  • Those who have a smartphone and can use the platform,
  • Volunteering and giving informed consent,
  • Turkish literate,
  • Individuals who do not report mental problems
  • Do not have children,
  • Marital status is married or single.

Exclusion Criteria:

  • Neurological disease (e.g., stroke, multiple sclerosis) or cognitive impairment,
  • Advanced-stage gynecologic cancers,
  • Failure to complete the follow-up period,
  • Initiation of oncologic treatment during the study period,
  • Non-completion or incomplete completion of the data collection instruments,
  • Non-use of the platform among participants allocated to the intervention group,
  • History of prior cancer treatment.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: Control- Routine information
The control group will be given an educational brochure with similar features for fertility preservation.
Eksperimentel: İntervention- Using the educational platform
Prof. Dr. Cemil Taşçıoğlu City Hospital will divide female patients of reproductive age (18-45 years) who have been diagnosed with gynecological cancer (early-stage cervical, ovarian, tubal, and endometrial cancer) and have not yet started treatment, and who have been referred for egg/ovarian tissue/embryo freezing, into two groups. The intervention group will use the cloud-based sustainable education platform developed for fertility preservation within the scope of the study. The control group will be given an educational brochure with similar features for fertility preservation.
In this study, a modular cloud-based platform will be developed to raise awareness about fertility preservation.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Awareness rates regarding fertility preservation options among patients in the experimental and control groups
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
These data will be obtained through the answers given to the "Awareness status questionnaire for fertility protection".
Change from beginning of the study and after 3 weeks of after the mobile application is given
Acceptance of fertility preservation
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
number of patients undergoing fertility preservation procedures
Change from beginning of the study and after 3 weeks of after the mobile application is given
fertility preservation knowledge scores
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
The Fertility Health Knowledge Scale was developed to evaluate individuals' level of knowledge about fertility health; The Turkish validity and reliability study of the scale was conducted. In this study, the knowledge level of the participants regarding fertility/fertility preservation will be evaluated based on the knowledge score using the scale in question.
Change from beginning of the study and after 3 weeks of after the mobile application is given
fertility preservation attitude scores
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
The Attitudes Toward Fertility and Childbearing Scale was developed to evaluate the attitudes of women who have not yet become mothers towards fertility and childbearing. The Turkish validity and reliability study of the scale was conducted. In this study, participants' attitude scores (sub-dimensions and total attitude level) towards fertility and childbearing will be evaluated using the scale in question.
Change from beginning of the study and after 3 weeks of after the mobile application is given

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Nezihe KIZILKAYA BEJI, Professor, Biruni University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

2. september 2026

Primær færdiggørelse (Anslået)

31. december 2026

Studieafslutning (Anslået)

1. januar 2027

Datoer for studieregistrering

Først indsendt

8. juni 2026

Først indsendt, der opfyldte QC-kriterier

8. juni 2026

Først opslået (Faktiske)

11. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

12. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. juni 2026

Sidst verificeret

1. juni 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

The inverstigators did not obtain permission from the participants to share their data with other researchers.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner